Ownership and insider activity for Impact BioMedical Inc. (IBO): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions.
Price
| Price | $0.50 |
| Market Cap | $54M |
| Exchange | AMEX |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-03-25 | Macko Todd D | S-Sale | 1,600 | $961 |
| 2026-03-27 | Macko Todd D | S-Sale | 43,400 | $24K |
| 2026-03-23 | Grady Jason | S-Sale | 50,000 | $33K |
| 2025-05-22 | DSS, INC. | S-Sale | 115,600 | $63K |
| 2025-05-27 | DSS, INC. | S-Sale | 45,400 | $25K |
| 2025-05-22 | DSS, INC. | S-Sale | 115,600 | $63K |
| 2025-05-27 | DSS, INC. | S-Sale | 45,400 | $25K |
| 2025-04-04 | DSS, INC. | S-Sale | 890,800 | $845K |
| 2025-04-03 | Chan Heng Fai Ambrose | S-Sale | 351,555 | $174K |
| 2025-04-02 | Chan Heng Fai Ambrose | S-Sale | 300,000 | $174K |
Balance Sheet (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $72347 | $46000 | $2000 | $1000 | $2.0M | $3000 |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | $197000 | $16000 | $331000 | $184000 | $203000 |
| Inventory | 0 | 0 | 0 | 0 | 0 | $63000 |
| Total Current Assets | $107347 | $287000 | $122000 | $332000 | $2.4M | $411000 |
| Property, Plant & Equipment | 0 | 0 | $276000 | $287000 | $17000 | 0 |
| Goodwill | $25.1M | $25.1M | $25.1M | $25.1M | 0 | 0 |
| Intangible Assets | $22.3M | $21.1M | $20.0M | $18.9M | $17.8M | $17.0M |
| Total Assets | $48.1M | $56.4M | $46.5M | $44.6M | $20.3M | $17.4M |
| Accounts Payable | $9267 | $115000 | $539000 | $832000 | $314000 | $347000 |
| Short-term Debt | $1.1M | $12.5M | $10.0M | $12.1M | $8.9M | 0 |
| Total Current Liabilities | $1.1M | $12.6M | $10.6M | $13.1M | $9.8M | $1.2M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $6.3M | $16.5M | $13.8M | $16.4M | $13.1M | $1.9M |
| Retained Earnings | -$271224 | -$1.6M | -$8.6M | -$13.0M | -$37.7M | -$49.5M |
| Total Equity | $37.9M | $36.6M | $29.6M | $25.2M | $4.3M | $12.6M |
| Total Debt | $1.1M | $12.5M | $10.0M | $12.1M | $8.9M | 0 |
| Net Debt | $986882 | $12.5M | $10.0M | $12.1M | $6.9M | -$3000 |
| Working Capital | -$961418 | -$12.4M | -$10.5M | -$12.8M | -$7.3M | -$751000 |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 0.16 |
Profitability
| Return on Equity | 13.70% |
| Return on Invested Capital | 14.91% |
| Return on Assets | 4.71% |
| Gross Margin | -1111.43% |
| Operating Margin | -14562.86% |
| Net Margin | 2254.29% |
Related companies: ADIL · AIM · BCLI · CYCN · MLEC · NRSN · QNRX
Explore sector: Healthcare · Biotechnology
More sections of IBO: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks